News

Plus, news about In­vivyd: Dana­her’s tar­iffs hit: The life sci­ences com­pa­ny cur­rent­ly ex­pects the costs of tar­iffs to be “some­thing like $350 mil­lion” in 2025 … ...
John D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 15 years. Aside from his ...
Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can … ...
The planned ex­it of long­stand­ing Pfiz­er CSO Mikael Dol­sten comes at a piv­otal mo­ment for the huge drug­mak­er. The Covid-19 vac­cine au­ra has ful­ly worn … ...
The Bio­med­ical Ad­vanced Re­search and De­vel­op­ment Au­thor­i­ty (BAR­DA) has grant­ed up to $453 mil­lion to Vaxart to re­vive its work on an oral Covid-19 vac­cine … ...
Be­low are no­table up­dates from the Amer­i­can Acad­e­my of Der­ma­tol­ogy’s an­nu­al meet­ing over the week­end: ...
No­var­tis pro­vid­ed a peek Sat­ur­day of how it might ex­pand de­vel­op­ment of its ex­per­i­men­tal drug remi­bru­ti­nib, a BTK in­hibitor be­ing test­ed in a range of … ...
The team of Ger­man re­searchers who first re­port­ed clin­i­cal da­ta back­ing the idea of us­ing CAR-T cell ther­a­pies to treat au­toim­mune dis­or­ders has spelled out … ...
Pfiz­er’s lat­est two-at-once vac­ci­na­tion mes­sag­ing taps in­to a hol­i­day theme. A TV com­mer­cial and Tik­Tok ad both cel­e­brate “pie sea­son” with the mes­sage that even … ...
As Eli Lil­ly launch­es its new­ly ap­proved weight loss med Zep­bound to much fan­fare, No­vo Nordisk is toss­ing a next-gen can­di­date in the ring. … ...
HHS on Fri­day an­nounced its se­lec­tions for the next-gen­er­a­tion of Covid-19 vac­cine can­di­dates to re­ceive $500 mil­lion in fund­ing as part of the gov­ern­ment’s Project … ...
When ac­tor Bel­lamy Young was grow­ing up, her fa­ther suf­fered from a brain dis­or­der called he­pat­ic en­cephalopa­thy (HE) caused by cir­rho­sis of the liv­er. … ...